Obstructive sleep apnea syndrome (OSAS) is associated with mild to severe cardiovascular risks. The most common standard treatment for OSAS, continuous positive airway pressure, was found to have beneficial effects on cardiovascular sequelae of OSAS. Additionally, commercial companies promote nonprescription treatments for OSAS. These products frequently lack scientific support for their efficacy and need further research. We report an objective test of magnetic therapy, one such product, in a patient with OSAS and cardiovascular comorbidities. Two nights of polysomnographic recording using the split-night protocol did not reveal any consistent differences in OSAS symptoms whether the patient slept with or without the magnetic equipment. It was concluded that magnetic treatment was unsuccessful in reducing OSAS symptoms in our patient and may even increase possible cardiovascular and stroke risks by preventing the patient from pursuing an adequate medical treatment, such as continuous positive airway pressure.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230–1235
Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea. A 7-year follow-up. Am J Respir Crit Care Med 2002;166:159–165
Meoli AL, Rosen CL, Kristo D et al. Nonprescription treatments of snoring or obstructive sleep apnea: an evaluation of products with limited scientific evidence. Sleep 2003;26:619–624
Edinger JD, Fins AI, Glenn DM et al. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints?. J Consult Clin Psychol 2000;68:586–593
Bixler EO, Vgontzas AN, Lin H-M et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000;160:2289–2295
Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep-apnea, and hypertension in a large community-based study. JAMA 2000;283:1829–1836
Ohayon MM, Guilleminault C, Priest RG, Zulley J, Smirne S. Is sleep-disordered breathing an independent risk factor for hypertension in the general population (13,057 subjects)?. J Psychosom Res 2000;48:593–601
Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease. Long-term prognosis. Am J Respir Crit Care Med 2001;164:1910–1913
Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke 2001;32:1271–1278
Neau J-P, Paquereau J, Meurice J-C, Chavagnat J-J, Gil R. Stroke and sleep apnoea: cause or consequence?. Sleep Med Rev 2002;6:457–469
Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T. Nasal continuous positive airway pressure changes blood pressure “non-dippers” to “dippers” in patients with obstructive sleep apnea. Sleep 1999;22:849–853
Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68–73
Suzuki M, Otsuka K, Guilleminault C. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993;16:545–549
Pepperell JC, Ramdassingh-Dow S, Crosthwaite N et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel trial. Lancet 2002;359:204–210
Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers”. Sleep 1996;19:378–381
Narciewicz K, Kato M, Phillips BG, Pesek C, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999;100:2332–2335
Dexter D. Magnetic therapy is ineffective for the treatment of snoring and obstructive sleep apnea syndrome. Wis Med J 1997;96:35–37
About this article
Cite this article
Dagan, Y., Borodkin, K. The Ineffectiveness of Magnotherapy in a Patient with Obstructive Sleep Apnea Syndrome and Cardiovascular Comorbidity. Sleep Breath 8, 209–212 (2004). https://doi.org/10.1007/s11325-004-0209-x
- Obstructive sleep apnea syndrome
- magnotherapy, cardiovascular comorbidity